全球醫藥及醫療設備綜合產品市場規模、佔有率、趨勢及成長分析報告（2026-2034）

預計醫藥和醫療設備綜合市場將從 2025 年的 1,760.2 億美元成長到 2034 年的 3,527.5 億美元，2026 年至 2034 年的複合年成長率為 8.03%。

由於市場對能夠提高療效和患者便利性的綜合醫療解決方案的需求不斷成長，全球醫藥醫療設備一體化（PHEV）市場正在快速擴張。 PHEV 透過將藥物與醫療設備結合，能夠更有效地提供治療。例如，預填充式注射器、吸入器、胰島素輸注裝置以及用於各種醫療治療的藥物釋放型支架等。

慢性病盛行率上升、先進藥物輸送系統的廣泛應用以及醫療設備技術的進步是推動市場成長的主要因素。製藥公司正在加速研發複合產品，旨在提高藥物輸送的精準度和患者依從性。此外，醫療保健投資的增加以及監管機構對創新療法的支持也促進了市場擴張。

展望未來，隨著醫療機構採用更個人化和高效的治療方法，藥物-醫療設備組合市場預計將持續成長。生物技術、數位健康技術和智慧藥物傳輸系統的進步將進一步提升產品功能。隨著醫療產業不斷致力於改善治療效果和提升患者便利性，該市場有望保持持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球醫藥及醫療設備綜合產品市場：依產品類別分類

• 市場分析、洞察與預測
• 藥物釋放型支架
• 點滴幫浦
• 動態療法
• 創傷護理複合產品
• 預填充式注射器
• 藥物釋放型球囊
• 噴霧器
• 吸入器
• 經皮吸收系統
• 整形外科複合產品
• 抗菌導管

第5章 全球醫藥醫療設備綜合市場：依應用領域分類

• 市場分析、洞察與預測
• 心血管疾病
• 糖尿病
• 呼吸系統疾病
• 癌症治療
• 抗菌應用
• 其他用途

第6章 全球醫藥及醫療設備組合產品市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院和診所
• 門診手術中心
• 居家醫療環境
• 其他最終用戶

第7章 全球醫藥及醫療設備綜合產品市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott Laboratories
  • AbbVie Inc
  • Alcon Inc
  • Bausch Health Companies Inc
  • Baxter International Inc
  • Bayer AG
  • Becton
  • Dickinson And Company
  • Boston Scientific Corporation
  • Glaxo SmithKline Plc
  • Johnson & Johnson
  • Kaleo Inc
  • Medtronic Plc
  • Novartis AG
  • Sinomed

The Drug Device Combination Products Market size is expected to reach USD 352.75 Billion in 2034 from USD 176.02 Billion (2025) growing at a CAGR of 8.03% during 2026-2034.

The Global Drug Device Combination Products Market is expanding rapidly due to the increasing demand for integrated healthcare solutions that improve treatment effectiveness and patient convenience. Drug device combination products combine pharmaceutical drugs with medical devices to deliver therapies more efficiently. Examples include prefilled syringes, inhalers, insulin delivery devices, and drug-eluting stents used in various medical treatments.

Market growth is driven by rising chronic diseases, increasing adoption of advanced drug delivery systems, and technological advancements in medical devices. Pharmaceutical companies are increasingly developing combination products to enhance drug delivery accuracy and improve patient compliance. In addition, growing healthcare investments and regulatory support for innovative treatment solutions are contributing to the expansion of the market.

Looking ahead, the drug device combination products market is expected to grow as healthcare providers adopt more personalized and efficient treatment methods. Advances in biotechnology, digital health technologies, and smart drug delivery systems will further enhance product capabilities. As the healthcare industry continues to focus on improving treatment outcomes and patient convenience, the market is likely to witness sustained growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Drug-Eluting Stents
• Infusion Pumps
• Photodynamic Therapy
• Wound Care Combination Product
• Prefilled Syringes
• Drug-Eluting Balloons
• Nebulizers
• Inhalers
• Transdermal Delivery Systems
• Orthopedic Combination Products
• Antimicrobial Catheters

By Application

• Cardiovascular Disorders
• Diabetes
• Respiratory Problems
• Cancer Treatment
• Antimicrobial Application
• Other Applications

By End-Use

• Hospitals And Clinics
• Ambulatory Surgical Centers
• Home Care Settings
• Other End-Users

COMPANIES PROFILED

• Abbott Laboratories, AbbVie Inc, Alcon Inc, Bausch Health Companies Inc, Baxter International Inc, Bayer AG, Becton, Dickinson and Company, Boston Scientific Corporation, Glaxo SmithKline plc, Johnson Johnson, Kaleo Inc, Medtronic plc, Novartis AG, Sinomed
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Drug-Eluting Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Infusion Pumps Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Photodynamic Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Wound Care Combination Product Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Prefilled Syringes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Drug-Eluting Balloons Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Nebulizers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Inhalers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. Transdermal Delivery Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.11. Orthopedic Combination Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.12. Antimicrobial Catheters Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Cardiovascular Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Respiratory Problems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Cancer Treatment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Antimicrobial Application Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Home Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Other End-Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DRUG DEVICE COMBINATION PRODUCTS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott Laboratories
  • 9.2.2 AbbVie Inc
  • 9.2.3 Alcon Inc
  • 9.2.4 Bausch Health Companies Inc
  • 9.2.5 Baxter International Inc
  • 9.2.6 Bayer AG
  • 9.2.7 Becton
  • 9.2.8 Dickinson And Company
  • 9.2.9 Boston Scientific Corporation
  • 9.2.10 Glaxo SmithKline Plc
  • 9.2.11 Johnson & Johnson
  • 9.2.12 Kaleo Inc
  • 9.2.13 Medtronic Plc
  • 9.2.14 Novartis AG
  • 9.2.15 Sinomed